source
- Expanding ctDNA Applications to RCC and Germ Cell TumorsExperts explain how ctDNA tracking in metastatic cancer guides therapy tweaks, flags relapse early, and where it fails in brain/peritoneal disease.onclive · 2mo ago↗ source
- RAPNO Criteria and MRI Assessment in PLGG: Recommendations vs. Real-World PracticeLearn how clinicians weigh symptoms, MRI changes and family goals to decide when a child’s tumor needs treatment—beyond simple size cutoffs.onclive · 2mo ago↗ source
- ctDNA in Metastatic Urothelial CarcinomaExperts explain how ctDNA tracking in metastatic cancer helps tailor immunotherapy, spot relapse early, and guide dose breaks—plus key limitations.onclive · 2mo ago↗ source